#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic malignant melanoma Herpes simplex Cardiac sarcoidosis Short-bowel syndrome Li-Fraumeni syndrome Haemophilia Cholangiosarcoma Leukodystrophy Sarcoma Marginal zone lymphoma refractory Ewing's sarcoma recurrent Juvenile chronic myelomonocytic leukaemia Neuroendocrine tumour of the lung Monogenic diabetes Acute hepatic failure More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Life with Disease Mastocytosis – Treatment Hereditary motor and sensory neuropathy – Diagnostics Tuberous sclerosis complex – Treatment Adrenogenital syndrome – Trials in Disease Adrenocortical carcinoma – Diagnostics Glomerulonephritis membranous Alport’s syndrome – Treatment Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Antithrombin III deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clotrimazole Trimethoprim Levamisole Hydrochloride Tebipenem Pivoxil Hydrobromide Alitretinoin Silibinin SECRETIN SYNTHETIC HUMAN Pabinafusp Alfa Mesenchymal Cells Xanthum Gum Escitalopram Oxalate Zolbetuximab Emibetuzumab Tolebrutinib Canakinumab Mometasone Furoate Monohydrate Mk-1084 Metformin Tivozanib Ivermectin More therapies…

    Learn about Your Condition

    Procedural pain Laryngeal leukoplakia Ocular hypertension Pancreatic fistula Cognitive disorder Iron deficiency Myeloid leukaemia Pericarditis Systemic sclerosis pulmonary Diffuse large B-cell lymphoma Diabetic gastroparesis Atopic keratoconjunctivitis Parkinson's disease Arterial stiffness Vestibular disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic hepatitis B

  • Study comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • ALG-000184
    • Tenofovir Disoproxil
    Bulgaria France Italy Romania Spain

  • Study on the Safety and Efficacy of a Hepatitis B Vaccine with Hepatitis B Surface Antigen (rDNA), MVA-HBVAC, and Mosaic HBcoreAg for Adults with Chronic Hepatitis B

    Recruiting

    1 1 1
    Investigated Drugs:
    • Mosaic Hbcoreag
    • Mva-Hbvac
    Germany Spain

  • A study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • GRNA1599
    France

  • Study of Tenofovir Alafenamide for Children and Teens with Chronic Hepatitis B

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Tenofovir Alafenamide
    Romania

  • Study of GSK3965193 and Bepirovirsen for People Living with Chronic Hepatitis B Infection and Healthy Participants

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Gsk3965193B
    • Bepirovirsen
    France Italy

  • Study on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Entecavir
    • Tenofovir Disoproxil
    • Tenofovir Alafenamide
    Belgium
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!